CTRV - ContraVir Pharmaceuticals Inc.
Previous close
3.58
3.580 100.000%
Share volume: 0
Last Updated: Mon 22 Jul 2019 10:00:00 PM CEST
Pharmaceuticals: Other:
0%
PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
Summary score
25%
Profitability
40%
Dept financing
22%
Liquidity
6%
Performance
15%
Sector
Health Technology
Industry
Pharmaceuticals: Other
Long-term ratios 2015 - 2019
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-123.66%
Return on assets
-41.28%
Return on sales
0%
Return on invested capital
-537.92%
Total debt ratio
83.29%
Debt ratio change over timeo
-1.19%
Current Ratio
1.21%
Quick Ratio
0%
Cash Position Ratio
1.25%
Short-term ratios 2018 - 2019
The data are presented for the financials results of the quarters of the last year.
Return on equity
-19.97%
Return on assets
-34.1%
Return on sales
0%
Return on invested capital
75.62%
Total debt ratio
86.19%
Debt ratio change over timeo
-1.52%
Current Ratio
0.94%
Quick Ratio
0%
Cash Position Ratio
1.03%
Last quarter ratios 2019
The data are presented for the financials results of the last quarter.
Return on equity
-311.1%
Return on assets
-24.31%
Return on sales
0%
Return on invested capital
-79.22%
Total debt ratio
91.83%
Debt ratio change over time
-1.98%
Current Ratio
0.55%
Quick Ratio
0%
Cash Position Ratio
0.49%
Performance ratios (change over 4 years) 2015 - 2019
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-202.3%
Return on assets
-94.96%
Return on sales
0%
Return on invested capital
-557.79%
Total debt ratio
-118.98%
Debt ratio change over time
-1.19%
Current Ratio
-0.93%
Quick Ratio
0%
Cash Position Ratio
-0.81%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | CTRV | MYOK | MDCO | ARQL |
|---|---|---|---|---|
| Return on equity | -123.66% | -5.34% | -94.71% | -29.43% |
| Return on assets | -41.28% | -4.78% | -6.46% | -12.15% |
| Return on sales | 0% | 0% | -592.81% | 0% |
| Return on invested capital | -537.92% | -109.05% | -41.38% | 69.88% |
| Profitability | 25% | 50% | 0% | 25% |
| Total debt ratio | 83.29% | 16.31% | 87.02% | 40.22% |
| Debt ratio change over time | -1.19% | -0.98% | -7.86% | -0.55% |
| Dept financing | 24% | 5% | 25% | 37% |
| Current Ratio | 0.94% | 10.96% | 3.53% | 7.33% |
| Quick Ratio | 0% | 0% | 3.51% | 0% |
| Cash Position Ratio | 1.03% | 9.13% | 2.67% | 1.49% |
| Liquididy | 9% | 50% | 42% | 26% |
| Short-term ratios | CTRV | MYOK | MDCO | ARQL |
|---|---|---|---|---|
| Return on equity | -19.97% | -4.82% | 56.08% | -3.18% |
| Return on assets | -34.1% | -4.81% | -5.04% | -3.6% |
| Return on sales | 0% | 0% | -723.25% | 0% |
| Return on invested capital | 75.62% | 87.06% | -10.8% | 41.29% |
| Profitability | 47% | 25% | 25% | 37% |
| Total debt ratio | 86.19% | 8.82% | 103.15% | 30.53% |
| Debt ratio change over time | -1.52% | -1% | -9.46% | -0.76% |
| Dept financing | 21% | 2% | 25% | 32% |
| Current Ratio | 0.94% | 10.96% | 3.53% | 7.33% |
| Quick Ratio | 0% | 0% | 3.51% | 0% |
| Cash Position Ratio | 1.03% | 9.13% | 2.67% | 1.49% |
| Liquididy | 5% | 50% | 40% | 21% |